Market Analysis and Insights:
The global Neuroscience market size is projected to reach US$ 34 billion by 2028, from US$ 26 billion in 2021, at a CAGR of 3.7% during 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuroscience market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuroscience market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuroscience market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuroscience market.
Scope and Market Size:
Neuroscience market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuroscience market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
- Siemens Healthineers
- GE Healthcare
- Philips
- Canon
- Hitachi
- Medtronic
- Leica Microsystems
- Zeiss
- Nikon
- JEOL Ltd
- Natus Medical
- Nihon Kohden
- NeuroPace Inc
- Shimadzu Corporation
- Compumedics
- Noldus Information Technology
- Plexon
- NeuroNexus
- Phoenix Technology Group
Segment by Type
- Whole Brain Imaging
- Neuro-Microscopy
- Electrophysiology Technologies
- Neuro-Cellular Manipulation
- Stereotaxic Surgeries
- Animal Behavior
- Other
Segment by Application
- Academic Institutes
- Hospitals
- Research Institutes
- Other
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Rest of MEA
TABLE OF CONTENTS
1 REPORT OVERVIEW
- 1.1 STUDY SCOPE
- 1.2 MARKET ANALYSIS BY TYPE
- 1.2.1 GLOBAL NEUROSCIENCE MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028
- 1.2.2 WHOLE BRAIN IMAGING
- 1.2.3 NEURO-MICROSCOPY
- 1.2.4 ELECTROPHYSIOLOGY TECHNOLOGIES
- 1.2.5 NEURO-CELLULAR MANIPULATION
- 1.2.6 STEREOTAXIC SURGERIES
- 1.2.7 ANIMAL BEHAVIOR
- 1.3 MARKET BY APPLICATION
- 1.3.1 GLOBAL NEUROSCIENCE MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
- 1.3.2 ACADEMIC INSTITUTES
- 1.3.3 HOSPITALS
- 1.3.4 RESEARCH INSTITUTES
- 1.4 STUDY OBJECTIVES
- 1.5 YEARS CONSIDERED
2 GLOBAL GROWTH TRENDS
- 2.1 GLOBAL NEUROSCIENCE MARKET PERSPECTIVE (2017-2028)
- 2.2 NEUROSCIENCE GROWTH TRENDS BY REGION
- 2.2.1 NEUROSCIENCE MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
- 2.2.2 NEUROSCIENCE HISTORIC MARKET SIZE BY REGION (2017-2022)
- 2.2.3 NEUROSCIENCE FORECASTED MARKET SIZE BY REGION (2023-2028)
- 2.3 NEUROSCIENCE MARKET DYNAMICS
- 2.3.1 NEUROSCIENCE INDUSTRY TRENDS
- 2.3.2 NEUROSCIENCE MARKET DRIVERS
- 2.3.3 NEUROSCIENCE MARKET CHALLENGES AND RESTRAINTS
3 COMPETITION LANDSCAPE BY KEY PLAYERS
- 3.1 GLOBAL TOP NEUROSCIENCE PLAYERS BY REVENUE
- 3.1.1 GLOBAL TOP NEUROSCIENCE PLAYERS BY REVENUE (2017-2022)
- 3.1.2 GLOBAL NEUROSCIENCE REVENUE MARKET SHARE BY PLAYERS (2017-2022)
- 3.2 GLOBAL NEUROSCIENCE MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
- 3.3 PLAYERS COVERED: RANKING BY NEUROSCIENCE REVENUE
- 3.4 GLOBAL NEUROSCIENCE MARKET CONCENTRATION RATIO
- 3.4.1 GLOBAL NEUROSCIENCE MARKET CONCENTRATION RATIO (CR5 AND HHI)
- 3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY NEUROSCIENCE REVENUE IN 2021
- 3.5 NEUROSCIENCE KEY PLAYERS HEAD OFFICE AND AREA SERVED
- 3.6 KEY PLAYERS NEUROSCIENCE PRODUCT SOLUTION AND SERVICE
- 3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS
4 NEUROSCIENCE BREAKDOWN DATA BY TYPE
- 4.1 GLOBAL NEUROSCIENCE HISTORIC MARKET SIZE BY TYPE (2017-2022)
- 4.2 GLOBAL NEUROSCIENCE FORECASTED MARKET SIZE BY TYPE (2023-2028)
5 NEUROSCIENCE BREAKDOWN DATA BY APPLICATION
- 5.1 GLOBAL NEUROSCIENCE HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
- 5.2 GLOBAL NEUROSCIENCE FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
6 NORTH AMERICA
- 6.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE (2017-2028)
- 6.2 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY TYPE
- 6.2.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022)
- 6.2.2 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028)
- 6.2.3 NORTH AMERICA NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028)
- 6.3 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION
- 6.3.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022)
- 6.3.2 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028)
- 6.3.3 NORTH AMERICA NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028)
- 6.4 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY
- 6.4.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022)
- 6.4.2 NORTH AMERICA NEUROSCIENCE MARKET SHARE BY COUNTRY (2023-2028)
- 6.4.3 UNITED STATES
- 6.4.4 CANADA
7 EUROPE
- 7.1 EUROPE NEUROSCIENCE MARKET SIZE (2017-2028)
- 7.2 EUROPE NEUROSCIENCE MARKET SIZE BY TYPE
- 7.2.1 EUROPE NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022)
- 7.2.2 EUROPE NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028)
- 7.2.3 EUROPE NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028)
- 7.3 EUROPE NEUROSCIENCE MARKET SIZE BY APPLICATION
- 7.3.1 EUROPE NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022)
- 7.3.2 EUROPE NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028)
- 7.3.3 EUROPE NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028)
- 7.4 EUROPE NEUROSCIENCE MARKET SIZE BY COUNTRY
- 7.4.1 EUROPE NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022)
- 7.4.2 EUROPE NEUROSCIENCE MARKET SIZE BY COUNTRY (2023-2028)
- 7.4.3 GERMANY
- 7.4.4 FRANCE
- 7.4.5 U.K.
- 7.4.6 ITALY
- 7.4.7 RUSSIA
8 ASIA-PACIFIC
- 8.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE (2017-2028)
- 8.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY TYPE
- 8.2.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022)
- 8.2.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028)
- 8.2.3 ASIA-PACIFIC NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028)
- 8.3 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY APPLICATION
- 8.3.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022)
- 8.3.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028)
- 8.3.3 ASIA-PACIFIC NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028)
- 8.4 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY REGION
- 8.4.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY REGION (2017-2022)
- 8.4.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY REGION (2023-2028)
- 8.4.3 CHINA
- 8.4.4 JAPAN
- 8.4.5 SOUTH KOREA
- 8.4.6 SOUTHEAST ASIA
- 8.4.7 INDIA
- 8.4.8 AUSTRALIA
9 LATIN AMERICA
- 9.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE (2017-2028)
- 9.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY TYPE
- 9.2.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022)
- 9.2.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028)
- 9.2.3 LATIN AMERICA NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028)
- 9.3 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION
- 9.3.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022)
- 9.3.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028)
- 9.3.3 LATIN AMERICA NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028)
- 9.4 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY
- 9.4.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022)
- 9.4.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2023-2028)
- 9.4.3 MEXICO
- 9.4.4 BRAZIL
10 MIDDLE EAST & AFRICA
- 10.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE (2017-2028)
- 10.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY TYPE
- 10.2.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022)
- 10.2.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028)
- 10.2.3 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028)
- 10.3 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY APPLICATION
- 10.3.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022)
- 10.3.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028)
- 10.3.3 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028)
- 10.4 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY COUNTRY
- 10.4.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022)
- 10.4.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2023-2028)
- 10.4.3 TURKEY
- 10.4.4 GCC COUNTRIES
- 10.4.5 ISRAEL
11 KEY PLAYERS PROFILES
- 11.1 SIEMENS HEALTHINEERS
- 11.1.1 SIEMENS HEALTHINEERS COMPANY DETAILS
- 11.1.2 SIEMENS HEALTHINEERS BUSINESS OVERVIEW
- 11.1.3 SIEMENS HEALTHINEERS NEUROSCIENCE INTRODUCTION
- 11.1.4 SIEMENS HEALTHINEERS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.2 GE HEALTHCARE
- 11.2.1 GE HEALTHCARE COMPANY DETAILS
- 11.2.2 GE HEALTHCARE BUSINESS OVERVIEW
- 11.2.3 GE HEALTHCARE NEUROSCIENCE INTRODUCTION
- 11.2.4 GE HEALTHCARE REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.3 PHILIPS
- 11.3.1 PHILIPS COMPANY DETAILS
- 11.3.2 PHILIPS BUSINESS OVERVIEW
- 11.3.3 PHILIPS NEUROSCIENCE INTRODUCTION
- 11.3.4 PHILIPS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.4 CANON
- 11.4.1 CANON COMPANY DETAILS
- 11.4.2 CANON BUSINESS OVERVIEW
- 11.4.3 CANON NEUROSCIENCE INTRODUCTION
- 11.4.4 CANON REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.5 HITACHI
- 11.5.1 HITACHI COMPANY DETAILS
- 11.5.2 HITACHI BUSINESS OVERVIEW
- 11.5.3 HITACHI NEUROSCIENCE INTRODUCTION
- 11.5.4 HITACHI REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.6 MEDTRONIC
- 11.6.1 MEDTRONIC COMPANY DETAILS
- 11.6.2 MEDTRONIC BUSINESS OVERVIEW
- 11.6.3 MEDTRONIC NEUROSCIENCE INTRODUCTION
- 11.6.4 MEDTRONIC REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.7 LEICA MICROSYSTEMS
- 11.7.1 LEICA MICROSYSTEMS COMPANY DETAILS
- 11.7.2 LEICA MICROSYSTEMS BUSINESS OVERVIEW
- 11.7.3 LEICA MICROSYSTEMS NEUROSCIENCE INTRODUCTION
- 11.7.4 LEICA MICROSYSTEMS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.8 ZEISS
- 11.8.1 ZEISS COMPANY DETAILS
- 11.8.2 ZEISS BUSINESS OVERVIEW
- 11.8.3 ZEISS NEUROSCIENCE INTRODUCTION
- 11.8.4 ZEISS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.9 NIKON
- 11.9.1 NIKON COMPANY DETAILS
- 11.9.2 NIKON BUSINESS OVERVIEW
- 11.9.3 NIKON NEUROSCIENCE INTRODUCTION
- 11.9.4 NIKON REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.10 JEOL LTD
- 11.10.1 JEOL LTD COMPANY DETAILS
- 11.10.2 JEOL LTD BUSINESS OVERVIEW
- 11.10.3 JEOL LTD NEUROSCIENCE INTRODUCTION
- 11.10.4 JEOL LTD REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.11 NATUS MEDICAL
- 11.11.1 NATUS MEDICAL COMPANY DETAILS
- 11.11.2 NATUS MEDICAL BUSINESS OVERVIEW
- 11.11.3 NATUS MEDICAL NEUROSCIENCE INTRODUCTION
- 11.11.4 NATUS MEDICAL REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.12 NIHON KOHDEN
- 11.12.1 NIHON KOHDEN COMPANY DETAILS
- 11.12.2 NIHON KOHDEN BUSINESS OVERVIEW
- 11.12.3 NIHON KOHDEN NEUROSCIENCE INTRODUCTION
- 11.12.4 NIHON KOHDEN REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.13 NEUROPACE INC
- 11.13.1 NEUROPACE INC COMPANY DETAILS
- 11.13.2 NEUROPACE INC BUSINESS OVERVIEW
- 11.13.3 NEUROPACE INC NEUROSCIENCE INTRODUCTION
- 11.13.4 NEUROPACE INC REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.14 SHIMADZU CORPORATION
- 11.14.1 SHIMADZU CORPORATION COMPANY DETAILS
- 11.14.2 SHIMADZU CORPORATION BUSINESS OVERVIEW
- 11.14.3 SHIMADZU CORPORATION NEUROSCIENCE INTRODUCTION
- 11.14.4 SHIMADZU CORPORATION REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.15 COMPUMEDICS
- 11.15.1 COMPUMEDICS COMPANY DETAILS
- 11.15.2 COMPUMEDICS BUSINESS OVERVIEW
- 11.15.3 COMPUMEDICS NEUROSCIENCE INTRODUCTION
- 11.15.4 COMPUMEDICS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.16 NOLDUS INFORMATION TECHNOLOGY
- 11.16.1 NOLDUS INFORMATION TECHNOLOGY COMPANY DETAILS
- 11.16.2 NOLDUS INFORMATION TECHNOLOGY BUSINESS OVERVIEW
- 11.16.3 NOLDUS INFORMATION TECHNOLOGY NEUROSCIENCE INTRODUCTION
- 11.16.4 NOLDUS INFORMATION TECHNOLOGY REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.17 PLEXON
- 11.17.1 PLEXON COMPANY DETAILS
- 11.17.2 PLEXON BUSINESS OVERVIEW
- 11.17.3 PLEXON NEUROSCIENCE INTRODUCTION
- 11.17.4 PLEXON REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.18 NEURONEXUS
- 11.18.1 NEURONEXUS COMPANY DETAILS
- 11.18.2 NEURONEXUS BUSINESS OVERVIEW
- 11.18.3 NEURONEXUS NEUROSCIENCE INTRODUCTION
- 11.18.4 NEURONEXUS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
- 11.19 PHOENIX TECHNOLOGY GROUP
- 11.19.1 PHOENIX TECHNOLOGY GROUP COMPANY DETAILS
- 11.19.2 PHOENIX TECHNOLOGY GROUP BUSINESS OVERVIEW
- 11.19.3 PHOENIX TECHNOLOGY GROUP NEUROSCIENCE INTRODUCTION
- 11.19.4 PHOENIX TECHNOLOGY GROUP REVENUE IN NEUROSCIENCE BUSINESS (2017-2022)
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
- 13.1 RESEARCH METHODOLOGY
- 13.1.1 METHODOLOGY/RESEARCH APPROACH
- 13.1.2 DATA SOURCE
- 13.2 DISCLAIMER
- 13.3 AUTHOR DETAILS